Moderna begins trial of Omicron-specific vaccine booster

WASHINGTON: US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

© New Straits Times Press (M) Bhd